Matinas BioPharma Holdings, Inc.
MTNB
$0.87
-$0.01-1.14%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.08M | -24.25M | -21.13M | -22.91M | -23.25M |
| Total Depreciation and Amortization | 860.00K | 972.00K | 965.00K | 959.00K | 952.00K |
| Total Amortization of Deferred Charges | -18.00K | 0.00 | 0.00 | 0.00 | -26.00K |
| Total Other Non-Cash Items | 6.55M | 7.53M | 4.23M | 4.47M | 4.78M |
| Change in Net Operating Assets | 567.00K | -131.00K | -1.01M | -390.00K | 588.00K |
| Cash from Operations | -12.12M | -15.89M | -16.95M | -17.87M | -16.96M |
| Capital Expenditure | -- | -- | 0.00 | -16.00K | -218.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.21M | 9.21M | 11.67M | 3.12M | 12.46M |
| Cash from Investing | 7.21M | 9.21M | 11.67M | 3.11M | 12.24M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.00K | -5.00K | -5.00K | -4.00K | -4.00K |
| Issuance of Common Stock | 9.19M | 9.24M | 9.24M | 9.24M | 54.00K |
| Repurchase of Common Stock | -65.00K | -65.00K | -65.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.65M | -- | -- | -- | -- |
| Cash from Financing | 10.77M | 9.17M | 9.17M | 9.24M | 50.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.85M | 2.50M | 3.89M | -5.53M | -4.67M |